Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
2.490
+0.170 (7.33%)
Aug 28, 2026, 9:53 AM EDT - Market open
Dogwood Therapeutics Market Cap
Dogwood Therapeutics has a market cap or net worth of $84.64 million as of August 28, 2026. Its market cap has increased by 852.45% in one year.
Market Cap
84.64M
Enterprise Value
75.16M
1-Year Change
852.45%
Ranking
Category
Stock Price
$2.49
ChartMarket Cap Chart
Since December 17, 2020, Dogwood Therapeutics's market cap has decreased from $130.88M to $84.64M, a decrease of -35.33%. That is a compound annual growth rate of -7.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 84.64M | -31.56% |
| Dec 31, 2025 | 123.67M | 3,628.17% |
| Dec 31, 2024 | 3.32M | -70.04% |
| Dec 29, 2023 | 11.07M | 155.97% |
| Dec 30, 2022 | 4.33M | -89.85% |
| Dec 31, 2021 | 42.61M | -27.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 98.57M |
| Cognition Therapeutics | 97.95M |
| Adicet Bio | 96.88M |
| Fortress Biotech | 94.38M |
| Aldeyra Therapeutics | 93.51M |
| Acrivon Therapeutics | 93.42M |
| Rallybio | 89.67M |
| ImmuCell | 89.37M |